Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Thalassemia × Mesna × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 29 Precursor Cell Lymphoblastic Leukemia-Lymphoma 24 Leukemia 23 Sarcoma 16 Lymphoma, Non-Hodgkin 16 Leukemia, Myeloid, Acute 16 Hematologic Neoplasms 12 Hodgkin Disease 11 Myelodysplastic Syndromes 10 Neoplasms 9 Leukemia, Lymphocytic, Chronic, B-Cell 9 Breast Neoplasms 9 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Osteosarcoma 6 Neuroblastoma 6 Lymphoma, Large B-Cell, Diffuse 6 Burkitt Lymphoma 6 Multiple Myeloma 5 Lymphoma, Mantle-Cell 5 Lymphoma, Follicular 5 Retinoblastoma 4 Myeloproliferative Disorders 4 Melanoma 4 Leukemia, Biphenotypic, Acute 4 Hematologic Diseases 4 Central Nervous System Neoplasms 4 Wilms Tumor 3 Teratoma 3 Rhabdoid Tumor 3 Recurrence 3

Interventions

Cyclophosphamide 3 fludarabine phosphate 2 fludarabine 2 thymoglobulin 1 ruxolitinib 1 Whole-Body Irradiation 1 Tacrolimus 1 Rituximab 1 Peripheral Blood Stem Cell Transplantation 1 Panobinostat 1 Mycophenolic Acid 1 Mesna 1 Dexamethasone 1 Busulfan 1 Bortezomib 1 Alemtuzumab 1 AP 1903 reagent 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00578292 2020-05-01

THALLO

Baylor College of Medicine

Phase NA Terminated

10 enrolled 15 charts

Lymphoma, Follicular, Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡